1.1 Articolo su Rivista/Article

1.1 Articolo su Rivista/Article: [13719] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 4.281 a 4.300 di 13.719

Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient

2021-01-01 Vergaro, G.; Castiglione, V.; Poletti, R.; Buda, G.; Pucci, A.; Musetti, V.; Genovesi, D.; Aimo, A.; Passino, C.; Emdin, M.

Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure

2021-01-01 Vergaro, G.; Aimo, A.; Campora, A.; Castiglione, V.; Prontera, C.; Masotti, S.; Musetti, V.; Chianca, M.; Valleggi, A.; Spini, V.; Emdin, M.; Passino, C.

Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides

2021-01-01 Castiglione, V.; Vergaro, G.; Aimo, A.; Prontera, C.; Musetti, V.; Masotti, S.; Battaglia, D.; Di Cecco, P.; Emdin, M.; Passino, C.

Digoxin use in patients with cardiovascular diseases: An old remedy for future medicine?

2021-01-01 Barison, A.; Aimo, A.

Aspirin for primary prevention of cardiovascular disease: Advice for a decisional strategy based on risk stratification

2020-01-01 Aimo, A.; de Caterina, R.

Myocardial stress perfusion scintigraphy for outcome prediction in patients with severe left ventricular systolic dysfunction

2021-01-01 Gimelli, A.; Aimo, A.; Pasanisi, E. M.; Coceani, M. A.; Clemente, A.; Emdin, M.; Shaw, L. J.

The Relativity of Reference Values for Myocardial Perfusion Imaging

2021-01-01 Gimelli, A.; Aimo, A.

Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis

2020-01-01 Figliozzi, S.; Masci, P. G.; Ahmadi, N.; Tondi, L.; Koutli, E.; Aimo, A.; Stamatelopoulos, K.; Dimopoulos, M. -A.; Caforio, A. L. P.; Georgiopoulos, G.

The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction

2021-01-01 Aimo, A.; Castiglione, V.; Vergaro, G.; Panichella, G.; Senni, M.; Lombardi, C. M.; Emdin, M.

COVID-19 and myocarditis: a systematic review and overview of current challenges

2021-01-01 Castiello, T.; Georgiopoulos, G.; Finocchiaro, G.; Claudia, M.; Gianatti, A.; Delialis, D.; Aimo, A.; Prasad, S.

Remote Ischemic Conditioning in Ischemic Stroke and Myocardial Infarction: Similarities and Differences

2021-01-01 Saccaro, L. F.; Aimo, A.; Emdin, M.; Pico, F.

High-sensitivity cardiac troponins in pediatric population

2021-01-01 Clerico, A.; Aimo, A.; Cantinotti, M.

Response to the comment by Dr Yarlas

2021-01-01 Aimo, A.

Pirfenidone as a novel cardiac protective treatment

2021-01-01 Aimo, A.; Spitaleri, G.; Panichella, G.; Lupon, J.; Emdin, M.; Bayes-Genis, A.

Assessing Cardiac Response to Patisiran by Changes in Extracellular Volume: Potential Issues

2021-01-01 Barison, A.; Aimo, A.; Emdin, M.

Biomarkers for the diagnosis and management of heart failure

2021-01-01 Castiglione, V.; Aimo, A.; Vergaro, G.; Saccaro, L.; Passino, C.; Emdin, M.

Diagnostic algorithms for non-ST-segment elevation myocardial infarction: Open issues

2021-01-01 Clerico, A.; Aimo, A.; Zaninotto, M.; Plebani, M.

Reply: Natriuretic Peptide-Based Risk Prediction and Assessment of Treatment Effect: Revisited in This Era

2021-01-01 Gentile, F.; Aimo, A.; Passino, C.; Emdin, M.; Vergaro, G.

Overlapping Effects of miR-21 Inhibition and Drugs for Idiopathic Pulmonary Fibrosis: Rationale for Repurposing Nintedanib as a Novel Treatment for Ischemia/Reperfusion Injury

2021-01-01 Aimo, A.; Egea, O. I.; Emdin, M.; Bayes-Genis, A.

Indications of beta-adrenoceptor blockers in Takotsubo syndrome and theoretical reasons to prefer agents with vasodilating activity

2021-01-01 Aimo, A.; Pelliccia, F.; Panichella, G.; Vergaro, G.; Barison, A.; Passino, C.; Emdin, M.; Camici, P. G.

Titolo	Data di pubblicazione	Autore(i)
Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient	1-gen-2021	Vergaro, G.; Castiglione, V.; Poletti, R.; Buda, G.; Pucci, A.; Musetti, V.; Genovesi, D.; Aimo, A.; Passino, C.; Emdin, M.
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure	1-gen-2021	Vergaro, G.; Aimo, A.; Campora, A.; Castiglione, V.; Prontera, C.; Masotti, S.; Musetti, V.; Chianca, M.; Valleggi, A.; Spini, V.; Emdin, M.; Passino, C.
Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides	1-gen-2021	Castiglione, V.; Vergaro, G.; Aimo, A.; Prontera, C.; Musetti, V.; Masotti, S.; Battaglia, D.; Di Cecco, P.; Emdin, M.; Passino, C.
Digoxin use in patients with cardiovascular diseases: An old remedy for future medicine?	1-gen-2021	Barison, A.; Aimo, A.
Aspirin for primary prevention of cardiovascular disease: Advice for a decisional strategy based on risk stratification	1-gen-2020	Aimo, A.; de Caterina, R.
Myocardial stress perfusion scintigraphy for outcome prediction in patients with severe left ventricular systolic dysfunction	1-gen-2021	Gimelli, A.; Aimo, A.; Pasanisi, E. M.; Coceani, M. A.; Clemente, A.; Emdin, M.; Shaw, L. J.
The Relativity of Reference Values for Myocardial Perfusion Imaging	1-gen-2021	Gimelli, A.; Aimo, A.
Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis	1-gen-2020	Figliozzi, S.; Masci, P. G.; Ahmadi, N.; Tondi, L.; Koutli, E.; Aimo, A.; Stamatelopoulos, K.; Dimopoulos, M. -A.; Caforio, A. L. P.; Georgiopoulos, G.
The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction	1-gen-2021	Aimo, A.; Castiglione, V.; Vergaro, G.; Panichella, G.; Senni, M.; Lombardi, C. M.; Emdin, M.
COVID-19 and myocarditis: a systematic review and overview of current challenges	1-gen-2021	Castiello, T.; Georgiopoulos, G.; Finocchiaro, G.; Claudia, M.; Gianatti, A.; Delialis, D.; Aimo, A.; Prasad, S.
Remote Ischemic Conditioning in Ischemic Stroke and Myocardial Infarction: Similarities and Differences	1-gen-2021	Saccaro, L. F.; Aimo, A.; Emdin, M.; Pico, F.
High-sensitivity cardiac troponins in pediatric population	1-gen-2021	Clerico, A.; Aimo, A.; Cantinotti, M.
Response to the comment by Dr Yarlas	1-gen-2021	Aimo, A.
Pirfenidone as a novel cardiac protective treatment	1-gen-2021	Aimo, A.; Spitaleri, G.; Panichella, G.; Lupon, J.; Emdin, M.; Bayes-Genis, A.
Assessing Cardiac Response to Patisiran by Changes in Extracellular Volume: Potential Issues	1-gen-2021	Barison, A.; Aimo, A.; Emdin, M.
Biomarkers for the diagnosis and management of heart failure	1-gen-2021	Castiglione, V.; Aimo, A.; Vergaro, G.; Saccaro, L.; Passino, C.; Emdin, M.
Diagnostic algorithms for non-ST-segment elevation myocardial infarction: Open issues	1-gen-2021	Clerico, A.; Aimo, A.; Zaninotto, M.; Plebani, M.
Reply: Natriuretic Peptide-Based Risk Prediction and Assessment of Treatment Effect: Revisited in This Era	1-gen-2021	Gentile, F.; Aimo, A.; Passino, C.; Emdin, M.; Vergaro, G.
Overlapping Effects of miR-21 Inhibition and Drugs for Idiopathic Pulmonary Fibrosis: Rationale for Repurposing Nintedanib as a Novel Treatment for Ischemia/Reperfusion Injury	1-gen-2021	Aimo, A.; Egea, O. I.; Emdin, M.; Bayes-Genis, A.
Indications of beta-adrenoceptor blockers in Takotsubo syndrome and theoretical reasons to prefer agents with vasodilating activity	1-gen-2021	Aimo, A.; Pelliccia, F.; Panichella, G.; Vergaro, G.; Barison, A.; Passino, C.; Emdin, M.; Camici, P. G.

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 4.281 a 4.300 di 13.719

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext7140
open3918
reserved1562
restricted1057
embargoed30
partially open12